PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DOCU vs. PATH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DOCU and PATH is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

DOCU vs. PATH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DocuSign, Inc. (DOCU) and UiPath Inc. (PATH). The values are adjusted to include any dividend payments, if applicable.

-90.00%-80.00%-70.00%-60.00%-50.00%NovemberDecember2025FebruaryMarchApril
-62.30%
-84.78%
DOCU
PATH

Key characteristics

Sharpe Ratio

DOCU:

0.84

PATH:

-0.96

Sortino Ratio

DOCU:

1.73

PATH:

-1.26

Omega Ratio

DOCU:

1.21

PATH:

0.81

Calmar Ratio

DOCU:

0.46

PATH:

-0.61

Martin Ratio

DOCU:

3.30

PATH:

-1.35

Ulcer Index

DOCU:

11.77%

PATH:

39.62%

Daily Std Dev

DOCU:

46.09%

PATH:

55.74%

Max Drawdown

DOCU:

-87.57%

PATH:

-88.29%

Current Drawdown

DOCU:

-73.33%

PATH:

-87.66%

Fundamentals

Market Cap

DOCU:

$16.74B

PATH:

$5.79B

EPS

DOCU:

$5.08

PATH:

-$0.13

PEG Ratio

DOCU:

0.41

PATH:

0.55

Total Revenue (TTM)

DOCU:

$2.98B

PATH:

$1.43B

Gross Profit (TTM)

DOCU:

$2.35B

PATH:

$1.18B

EBITDA (TTM)

DOCU:

$372.31M

PATH:

-$148.55M

Returns By Period

In the year-to-date period, DOCU achieves a -8.06% return, which is significantly higher than PATH's -17.39% return.


DOCU

YTD

-8.06%

1M

-0.58%

6M

34.63%

1Y

42.01%

5Y*

-0.32%

10Y*

N/A

PATH

YTD

-17.39%

1M

-14.63%

6M

-15.32%

1Y

-52.68%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DOCU vs. PATH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DOCU
The Risk-Adjusted Performance Rank of DOCU is 7878
Overall Rank
The Sharpe Ratio Rank of DOCU is 8080
Sharpe Ratio Rank
The Sortino Ratio Rank of DOCU is 8181
Sortino Ratio Rank
The Omega Ratio Rank of DOCU is 7878
Omega Ratio Rank
The Calmar Ratio Rank of DOCU is 7272
Calmar Ratio Rank
The Martin Ratio Rank of DOCU is 8080
Martin Ratio Rank

PATH
The Risk-Adjusted Performance Rank of PATH is 1111
Overall Rank
The Sharpe Ratio Rank of PATH is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of PATH is 1010
Sortino Ratio Rank
The Omega Ratio Rank of PATH is 88
Omega Ratio Rank
The Calmar Ratio Rank of PATH is 1515
Calmar Ratio Rank
The Martin Ratio Rank of PATH is 1515
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DOCU vs. PATH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for DocuSign, Inc. (DOCU) and UiPath Inc. (PATH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DOCU, currently valued at 0.84, compared to the broader market-2.00-1.000.001.002.003.00
DOCU: 0.84
PATH: -0.96
The chart of Sortino ratio for DOCU, currently valued at 1.73, compared to the broader market-6.00-4.00-2.000.002.004.00
DOCU: 1.73
PATH: -1.26
The chart of Omega ratio for DOCU, currently valued at 1.21, compared to the broader market0.501.001.502.00
DOCU: 1.21
PATH: 0.81
The chart of Calmar ratio for DOCU, currently valued at 0.46, compared to the broader market0.001.002.003.004.005.00
DOCU: 0.46
PATH: -0.61
The chart of Martin ratio for DOCU, currently valued at 3.30, compared to the broader market-5.000.005.0010.0015.0020.00
DOCU: 3.30
PATH: -1.35

The current DOCU Sharpe Ratio is 0.84, which is higher than the PATH Sharpe Ratio of -0.96. The chart below compares the historical Sharpe Ratios of DOCU and PATH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.84
-0.96
DOCU
PATH

Dividends

DOCU vs. PATH - Dividend Comparison

Neither DOCU nor PATH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DOCU vs. PATH - Drawdown Comparison

The maximum DOCU drawdown since its inception was -87.57%, roughly equal to the maximum PATH drawdown of -88.29%. Use the drawdown chart below to compare losses from any high point for DOCU and PATH. For additional features, visit the drawdowns tool.


-90.00%-85.00%-80.00%-75.00%-70.00%-65.00%NovemberDecember2025FebruaryMarchApril
-73.33%
-87.66%
DOCU
PATH

Volatility

DOCU vs. PATH - Volatility Comparison

The current volatility for DocuSign, Inc. (DOCU) is 18.11%, while UiPath Inc. (PATH) has a volatility of 21.91%. This indicates that DOCU experiences smaller price fluctuations and is considered to be less risky than PATH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%NovemberDecember2025FebruaryMarchApril
18.11%
21.91%
DOCU
PATH

Financials

DOCU vs. PATH - Financials Comparison

This section allows you to compare key financial metrics between DocuSign, Inc. and UiPath Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab